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Abstract
Background: Presence of Bisphenol A (BPA) has been documented worldwide in a variety of human biological
samples. There is growing evidence that low level BPA exposure may impact placental tissue development and
thyroid function in humans. The aim of this present pilot study was to determine urinary concentrations of BPA
during the last trimester of pregnancy among a small subset of women in Mexico City, Mexico and relate these
concentrations to risk of delivering prematurely.
Methods: A nested case-control subset of 60 participants in the Early Life Exposure in Mexico to ENvironmental
Toxicants (ELEMENT) study in Mexico City, Mexico were selected based on delivering less than or equal to 37
weeks of gestation and greater than 37 weeks of gestation. Third trimester archived spot urine samples were
analyzed by online solid phase extraction coupled with high performance liquid chromatography isotope dilution
tandem mass spectrometry.
Results: BPA was detected in 80.0% (N = 48) of the urine samples; total concentrations ranged from < 0.4 μg/L to
6.7 μg/L; uncorrected geometric mean was 1.52 μg/L. The adjusted odds ratio of delivering less than or equal to
37 weeks in relation to specific gravity adjusted third trimester BPA concentration was 1.91 (95%CI 0.93, 3.91,
p-value = 0.08). When cases were further restricted to births occurring prior to the 37
th week (n = 12), the odds
ratio for specific-gravity adjusted BPA was larger and statistically significant (p < 0.05).
Conclusions: This is the first study to document measurable levels of BPA in the urine of a population of Mexican
women. This study also provides preliminary evidence, based on a single spot urine sample collected during the
third trimester, that pregnant women who delivered less than or equal to 37 weeks of gestation and prematurely
(< 37 weeks) had higher urinary concentrations of BPA compared to women delivering after 37 weeks.
Background
Bisphenol A (BPA, CAS no. 80-05-7) is produced in
high volume worldwide for use in a variety of industrial
and consumer products, such as epoxy resins used to
line food cans [1], polyester-styrene [2], and polycarbo-
nate plastics which make up some baby bottles and
other containers [3]. Due to this wide spread usage, the
primary exposure route in humans is thought to occur
via ingestion of food or water [4,5]. Calafat et al. docu-
mented extensive exposure to the general US population
in a subset of the 2003-2004 National Health and Nutri-
tion Examination Survey (NHANES), where 93% of the
2,517 participants had detectable BPA in their urine [6].
Additionally, other studies in the Netherlands [7],
Germany [8], China [9], Japan [10], and Norway [11]
have all found similar population wide exposure to BPA
in each respective country. Human studies have also
measured BPA in a variety of other human body fluids
and some tissues. Of potential concern to fetal and
infant health endpoints is the presence of BPA in folli-
cular and amniotic fluid [12], umbilical cord blood and
placental tissue [13], and breast milk [14].
BPA has been shown to have weak oestrogenic activity
and potentially impacts thyroid function [15,16]. Addi-
tionally, recent evidence from in vitro studies suggests
that fetal exposure to BPA can occur through placental
exchange [17] and that BPA exposure at doses (0.02 -
0.1 μg/mL) close to those found in some pregnant
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phoblast cells [18]. In animal studies, environmentally-
relevant concentrations of BPA have been associated
with low birth weight [19]. By contrast, there is no evi-
dence for this relationship or for a relationship with
gestational length in humans [20,21].
The primary aim of this pilot study was to determine
urinary concentrations of BPA during the last trimester
of pregnancy among 60 women, a subset of participants
in the Early Life Exposure in Mexico to ENvironmental
Toxicants (ELEMENT) study in Mexico City, Mexico. A
secondary aim of this study was to determine differences
in BPA concentrations between women who delivered
less than or equal to 37 weeks of gestation and after the
completion of 37 weeks of gestation. To our knowledge,
this is the first report on the biological monitoring of
BPA in Mexico.
Methods
Sample Population
T h ep r e s e n ts t u d yw a sn e s t e dw i t h i naM e x i c a nb i r t h
cohort study in which women were recruited during
prenatal visits at one of four clinics of the Mexican
Institute of Social Security in Mexico City between 2001
and 2003 and has been described elsewhere [22]. The
research protocol was approved by the Ethics and
Research Committees of all participating institutions.
The involvement of the Centers for Disease Control and
Prevention (CDC) laboratory was limited and deter-
mined not to constitute engagement in human subjects
research. The study was described in detail to all partici-
pating mothers and all study participants gave informed
consent.
Of the 1,853 women approached, 670 (36%) agreed to
participate in the cohort study. Of these, archived third
trimester urine samples, collected during 2001-2003,
were available for 518 nonsmoking women because
urine collection did not commence until after the initia-
tion of study recruitment had begun. In the present
nested case-control study conducted within these 518
women, 30 participants were selected randomly among
women who had completed 38 or more weeks of gesta-
tion at the time of delivery. Additionally, 30 participants
were selected among women who had delivered before
38 weeks of gestation at time of delivery, which included
12 women who delivered prior to 37 weeks.
Measures of Bisphenol-A in Urine
A spot (second morning void) urine sample was col-
lected from each woman during a third trimester visit
(earliest urine collection occurred during the 30
th week
of gestation) to the project’s research center and frozen
at -80°C. Samples were shipped on dry ice overnight to
the CDC, where the total urinary concentration of BPA
(free plus conjugated species) was measured using
online solid-phase extraction (SPE) coupled to isotope
dilution-high performance liquid chromatography
(HPLC) - tandem mass spectrometry (MS/MS) on a sys-
tem constructed from several HPLC Agilent 1100 mod-
ules (Agilent Technologies, Wilmington, DE) coupled to
a triple quadrupole API 4000 mass spectrometer
(Applied Biosystems, Foster City, CA). First, 100 μLo f
urine was treated with b-glucuronidase/sulfatase (Helix
pomatia, H1; Sigma Chemical Co., St. Louis, MO) to
hydrolyze the BPA-conjugated species. BPA was then
retained and concentrated on a C18 reversed-phase size-
exclusion SPE column (Merck KGaA, Germany), sepa-
rated from other urine matrix components using a pair
of monolithic HPLC columns (Merck KGaA), and
detected by negative ion-atmospheric pressure chemical
ionization-MS/MS. Low-concentration (~ 4 μg/L) and
high-concentration (~ 20 μg/L) quality control materials,
prepared with pooled human urine, were analyzed with
analytical standards, reagent blanks, and unknown sam-
ples (15). Specific gravity was measured at the University
of Michigan using a handheld digital refractometer
(ATAGO Company Ltd., Tokyo, Japan). BPA concentra-
tions were also corrected by creatinine (Cr; BPA con-
centrations expressed as μg/g creatinine), which was
measured at the University of Michigan using a Micro-
Lab AT Plus (Hamilton Co., Reno, NV, USA) and
Microplate Spectrophotometer (SpectraMax 340, Mole-
cular Devices, Sunnyvale, CA, USA).
Statistical Analysis
Descriptive statistics and identification of outliers, using
the generalized extreme studentized deviation method
[23] were performed. Exclusion of the two individuals
identified as outliers (who give birth to very early pre-
term, < 32 weeks of completed gestational length) did
not significantly alter any of our results and were
retained in final models. In our final study population
(N = 60) there were N = 12 (20%) individuals who deliv-
ered earlier than 37 weeks of completed gestational
length. All urinary BPA concentrations (creatinine or
specific gravity corrected and uncorrected) were log
transformed in order to stabilize variance. Maternal and
pregnancy characteristics were calculated and compared
between those participants who delivered greater than
37 weeks and less than or equal to 37 weeks of gestation
at time of delivery using Student’s t-tests (2-tailed) and
chi-square tests for continuous and categorical variables,
respectively.
We calculated geometric means and distribution per-
centiles for uncorrected (μg/L), specific gravity corrected
(μg/L), and creatinine corrected concentrations (μg/g
creatinine) of BPA. The limit of detection (LOD) for
BPA in a 0.1-mL urine sample was 0.4 μg/L. For
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Page 2 of 7concentrations below the LOD [N = 12 (20.0%)], an
imputed value equal to one-half the LOD (0.2 μg/L) was
used. BPA concentrations were corrected for urine dilu-
tion by specific gravity (SG) using the following formula:
Pc =P [ ( 1 . 0 1 4-1 ) / S G-1 ) ] ,w h e r eP c is the SG-adjusted
BPA concentration (ng/ml), 1.014 is the median SG
value among the present study population, P is the mea-
sured BPA concentration, and SG is the specific gravity
of the urine sample.
In preliminary crude analyses to assess whether women
who delivered less than or equal to 37 weeks of gestation
length had higher BPA concentrations than those who
delivered after 37 weeks, geometric mean concentrations
were compared between the two groups using t-tests (2-
tailed). To take into account potential confounding vari-
ables, multivariable logistic regression was used to model
the odds of delivering less than or equal to 37 weeks ver-
sus greater than 37 weeks of gestation. Variables consid-
ered in this analysis included maternal age, pre-
pregnancy body mass index, third trimester urinary
phthalate metabolites, parity, maternal education, marital
status, and the infant’s gender. Though we were unable
to assess urinary or serum cotinine levels due to financial
restraints, all of our participants were self-reported non-
smokers. Variables that did not differ between groups,
and did not statistically confound (change in effect esti-
mate of > 10%) in any of the models were not retained.
The variables that did appreciably change (> 10%) the
effect estimate in at least one of the models were
included in all models for consistency.
A subset sensitivity analysis was performed in order to
examine odds of delivering prematurely (< 37 weeks). In
these additional models participants who delivered at 37
weeks of gestation were first included as controls and
then excluded from the analysis. Data analysis and
regression diagnostics was performed using SAS version
9.2 (SAS Institute Inc., Cary, NC, USA).
Results
Maternal demographic characteristics for our final study
population and for those non-smoking participants who
delivered greater than 37 weeks, less than or equal to 37
weeks and preterm (< 37 weeks) are presented in
Table 1. There were no significant differences in mater-
nal age, maternal education, pre-pregnancy body mass
index, parity, marital status, or infant sex when compar-
ing term and preterm infants.
BPA was detected in 80.0% (N = 48) of the samples
with total concentrations ranging from 0.4 μg/L to 6.7
μg/L. The geometric mean and 95th percentile concen-
trations for our total study population were 1.52 μg/L
(1.45 μg/L specific gravity adjusted) and 5.7 μg/L (4.36
μg/L specific gravity adjusted), respectively (Table 2.)
Mothers who delivered less than or equal to 37 weeks
had a geometric mean BPA concentration of 1.84 ± 1.86
μg/L (1.71 ± 1.57 μg/L SG adjusted) compared with
mothers who gave birth after 37 weeks 0.97 ± 0.92 μg/L
[1.20 ± 1.02 μg/L SG adjusted (Student’s t-tests; p-value
= 0.01 and 0.11 for unadjusted and SG-adjusted BPA
concentrations, respectively)]. In addition, creatinine-
adjusted BPA values between mothers who delivered
less than or equal to 37 weeks and mothers who gave
birth after 37 weeks were 2.20 μg/L and 1.70 μg/L,
respectively (Student’s t-test; p-value = 0.15.)
Table 1 Maternal and pregnancy characteristics for participants who delivered > 37 weeks, ≤ 37 weeks, and those
participants who delivered preterm (< 37 weeks)
Characteristics Participants who
Delivered > 37 Weeks
(N = 30)
Participants who
Delivered ≤ 37 Weeks
(N = 30)
Participants who
Delivered Preterm
(< 37 weeks; N = 12)
Years of Maternal Age
[mean (SD)]
27.3 (5.9) 27.7 (6.2) 29.3 (5.9)
Years of Maternal Education [mean (SD)] 11.3 (2.5) 10.7 (3.6) 11.6 (2.9)
Prepregnancy BMI (kg/m
2)
[mean (SD)]
24.9 (4.4) 25.2 (3.8) 23.7 (4.2)
Parity [number (%)]
First Child 10 (33) 10 (33) 4 (33)
Not First Child 20 (67) 20 (67) 8 (67)
Marital status [number (%)]
Married 26 (87) 24 (80) 9 (75)
Single 4 (13) 6 (20) 3 (25)
Infant Sex [number (%)]
Male 15 (50) 13 (43) 5 (42)
Female 15 (50) 17 (57) 7 (58)
** p-value < 0.05.
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fitted to explore the relationship between third trimester
log transformed unadjusted, specific gravity adjusted,
and creatinine adjusted BPA concentrations and the
odds of delivering less than or equal to 37 weeks of
gestation (Table 3.) All final multivariable models
included covariates for maternal age, maternal education,
infant gender and parity. The adjusted odds ratio of deli-
vering less than or equal to 37 weeks in relation to speci-
fic gravity adjusted third trimester BPA concentration
was 1.91 (95%CI 0.93, 3.91, p-value = 0.08). In a sensitiv-
i t ya n a l y s i s ,c r u d el o g i s t i cr egression models were fitted
to quantify this relationship in regards to delivering pre-
maturely (< 37 weeks), acknowledging our small number
of preterm cases (N = 12). In these models, in which we
explored both including and then excluding women who
delivered in the 37
th week in the control group, there
were significantly increased odds of delivering prema-
turely with increasing specific gravity adjusted third tri-
mester BPA concentrations (Table 4). Addition of third
trimester urinary phthalate metabolites previously shown
to be related to risk of prematurity in this population
[24] as potential confounders didn’t appreciably change
the odds ratios in our analysis (data not shown).
The linear relationship between gestation length and
log transformed, specific gravity adjusted, third trimester
urinary BPA concentrations is presented in Figure 1. In
multivariate linear regression models adjusted for mater-
nal age, maternal education, parity, and infant sex, a 1-
log increase in third trimester BPA concentration was
associated with a 4.56 day (95%CI: -9.08, -0.04) decrease
in gestation length (results not shown).
Discussion
This is the first study to document measurable concen-
trations of BPA in the urine of a Mexican population.
Furthermore, the present study suggests, based on a sin-
gle spot urine sample collected during the third trime-
ster, that women who delivered less than or equal to 37
weeks of gestation and prematurely (< 37 weeks) had
higher concentrations of BPA in their urine compared
to women delivering after 37 weeks.
Geometric mean urinary BPA concentrations (1.52 μg/L
uncorrected, 1.95 μg/g Cr) in this pilot analysis from the
ELEMENT study were very similar to concentrations
among pregnant women in the Netherlands (1.1 μg/L
uncorrected, 1.7 μg/g Cr) [7], New York City (1.3 μg/L
uncorrected) [21], Cincinnati (2.0 μg/L uncorrected, 2.2
μg/g Cr) [25], and women in the general US population
from NHANES 2003-2004 (2.4 μg/L, 2.8 μg/g Cr) [6]. The
geometric mean concentration in our study was approxi-
mately one-half of that reported in a small (n = 10) subset
Table 2 Third Trimester Geometric Mean and Selected Percentiles of Uncorrected and Dilution Corrected Urinary
Bisphenol-A Concentrations Among Mexican Women
BPA
Metabolite
N Geometric Mean Percentile
10
th 25
th 50
th 75
th 90
th 95
th Max
All Participants
BPA (μg/L) uncorrected 60 1.52 0.20 0.55 0.95 1.80 3.15 5.70 6.70
BPA (μg/L) SG corrected 60 1.45 0.31 0.70 1.03 1.56 3.98 4.36 6.89
BPA (μg/g) Cr corrected 60 1.95 0.41 0.93 1.38 2.01 5.20 6.46 7.47
Women who Delivered (> 37 weeks)
BPA (μg/L) uncorrected 30 0.97 0.20 0.20 0.80 1.10 2.05 3.40 3.90
BPA (μg/L) SG corrected 30 1.20 0.31 0.58 1.01 1.40 2.45 4.20 4.20
BPA (μg/g) Cr corrected 30 1.70 0.31 0.69 1.31 1.79 4.00 6.09 6.18
Women who Delivered (≤ 37 weeks)
BPA (μg/L) uncorrected 30 1.84 0.35 0.70 1.05 2.20 5.70 6.40 6.70
BPA (μg/L) SG corrected 30 1.71 0.44 0.81 1.05 1.65 4.28 4.57 6.89
BPA (μg/g) Cr corrected 30 2.20 0.72 1.02 1.44 2.10 6.07 7.03 7.47
Subset of Women who Delivered Preterm (< 37 weeks)
BPA (μg/L) uncorrected 12 2.18 0.80 0.80 1.15 2.65 6.20 6.70 6.70
BPA (μg/L) SG corrected 12 1.94 0.93 1.04 1.41 2.63 3.91 4.57 4.57
BPA (μg/g) Cr corrected 12 2.54 1.08 1.44 1.69 3.00 5.40 7.47 7.47
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Lu n c o r r e c t e d ,5 . 9μg/g Cr) [11].
To date there has been limited human data on pre-
term birth, gestational length, and prenatal BPA expo-
sure. In the Children’s Environmental Health study,
Wolff et al. found no association between BPA exposure
during the third trimester and gestational length among
404 pregnant women in New York City [21]. In addition,
a small scale study (N = 40) in Southeastern Michigan
that measured BPA in blood of women at the time of
delivery also found no difference in gestational length
between women with blood BPA concentrations > 5 and
≤ 5 ng/mL[20]. However, unlike the present study, these
studies were not designed to assess preterm birth in rela-
tion to BPA exposure. Other small-scale human studies
of BPA exposure in pregnancy have reported increases in
the risk of spontaneous abortion [26], sister chromatid
exchanges [27], and abnormal fetal karyotype [28] with
increased BPA concentrations. As far as we are aware,
this is the first study to specifically assess the relationship
between BPA exposure biomarker concentrations during
pregnancy and preterm birth.
Preterm birth is likely a condition with multiple etiolo-
gies [29]. BPA may harm fetal growth and promote early
parturition through various mechanisms, as it has been
shown to disrupt a variety of biologic functions including
steroid hormone synthesis and metabolism [30,31], per-
oxisome proliferation [32], cytokine networks [18],
genotoxicity [33-35], and oxidative stress [36-40]. Low
doses of BPA also induced apoptosis and increased out-
put of matrix metalloproteinase-9, an enzyme associated
with preterm birth, in ovarian granulosa cells in dose-
dependent patterns [41,42]. Recently, it has been shown
that human primary cytotrophoblast cells undergo a
dose-dependent increase in TNF-a production and apop-
tosis with increasing environmentally relevant (0.0002 to
0.2 ug/mL) levels of BPA [18]. Supporting these initial
results, Morck et al. also demonstrated that similar levels
of BPA exposure can induce cell death in a human chor-
iocarcinoma cell line and increase secretion of b-hCG
and caspase-3 cleavage in first trimester human chorionic
villous explant cultures [17].
Our study has several limitations including its small
sample size. Gestational length was estimated by date of
maternally-recalled last menstrual period which may be
an unreliable measure, varying as much as ± 7-21 days,
depending on a host of factors including nutrition, phy-
sical activity, smoking, alcohol consumption, stress, and
inter-pregnancy interval [43-46]. Because urinary BPA
w a so n l ym e a s u r e da tas i n g l etime point in this study,
the potential for measurement error exists since expo-
sure is likely to be variable over time [47]. However,
unless errors in last menstrual period recall were asso-
ciated with BPA urinary concentrations and/or measure-
ment error of BPA concentrations was systematic in
relation to gestational age, one would expect that, on
average, any bias in effect estimates would be toward
the null.
Table 3 Unadjusted and Adjusted Odd Ratios for log
transformed third trimester urinary bisphenol-A
concentrations among women who delivered > 37 weeks
compared to women who delivered ≤ 37 weeks
n1 n2 Unadjusted Adjusted
a
OR (95%CI) OR (95%CI)
Log BPA (ug/L SG adjusted) 30 30 1.69 (0.88, 3.25) 1.91 (0.93, 3.91)
Log BPA (ug/g Cr) 30 30 1.58 (0.85, 2.97) 1.78 (0.90, 3.52)
a Adjusted for: Maternal Age, Maternal Education, Parity, Sex.
Table 4 Sensitivity Analysis of Unadjusted Odds Ratios
for log transformed third trimester urinary bisphenol-A
concentrations among women who delivered ≥ 37 weeks
(and excluding those who delivered at 37 weeks)
compared to women who delivered preterm (< 37 weeks)
Unadjusted
n1 n2 OR (95%CI)
Including participants who delivered at 37 weeks as controls
Log BPA (ug/L SG adjusted) 48 12 2.50 (1.05, 5.96)
Log BPA (ug/g Cr) 48 12 2.11 (0.93, 4.80)
Excluding participants who delivered at 37 weeks
Log BPA (ug/L SG adjusted) 30 12 3.24 (1.10, 9.60)
Log BPA (ug/g Cr) 30 12 2.36 (0.93, 6.00)
Figure 1 Relationship between gestational length and log
transformed third trimester urinary bisphenol-A concentrations
among Mexican women (N = 60). The dotted line represents the
259 day (37 week) of gestation cutoff for preterm delivery.
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In conclusion, the results from this pilot analysis suggest
that a group of pregnant women residing in Mexico City
have similar urinary concentrations of BPA compared to
women in the United States and other developed coun-
tries. In addition, based on the analysis of one spot
u r i n es a m p l ec o l l e c t e dd u r i n gt h et h i r dt r i m e s t e ro f
pregnancy, these results provide suggestive evidence that
women who delivered less than or equal to 37 weeks of
gestation and prematurely (< 37 weeks) have higher
urinary concentrations of BPA compared to women
who delivered greater than 37 weeks.
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